4.7 Article

Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 23, Issue 1, Pages 81-90

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.3144

Keywords

-

Funding

  1. Intramural Research Program of the Vaccine Research Center, US National Institute of Allergy and Infectious Diseases (NIAID)
  2. Division of AIDS, NIAID, NIH [1U01-AI116086-01, R21-AI112389]
  3. Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery [OPP1033102]
  4. IAVI
  5. Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery grant (CHAVI-ID) [UM1 AI100645]
  6. Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]
  7. US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]
  8. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER
  9. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024, UM1AI100645, U01AI116086, ZICAI005114, ZICAI005113, ZICAI005111, R21AI112389] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Broadly neutralizing antibodies (bNAbs) against HIV-1 Env V1V2 arise in multiple donors. However, atomic-level interactions had previously been determined only with antibodies from a single donor, thus making commonalities in recognition uncertain. Here we report the cocrystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third donor. These V1 V2-directed bNAbs used strand-strand interactions between a protruding antibody loop and a V1V2 strand but differed in their N-glycan recognition. Ontogeny analysis indicated that protruding loops develop early, and glycan interactions mature over time. Altogether, the multidonor information suggested that V1V2-directed bNAbs form an 'extended class', for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. The ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available